Firebrick Pharma Management
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Peter Molloy (68 yo)
Dr. Peter Laurence Molloy, BSc, MBA, FAICD is the Founder, Executive Chairman and Chief Executive Officer of Firebrick Pharma Limited since April 12, 2012. He served as Managing Director and Chief Executiv...
CEO Compensation Analysis
|Date||Total Comp.||Salary||Company Earnings|
|Jun 30 2022||AU$324k||AU$252k|
|Mar 31 2022||n/a||n/a|
|Dec 31 2021||n/a||n/a|
|Sep 30 2021||n/a||n/a|
|Jun 30 2021||AU$140k||AU$140k|
Compensation vs Market: Peter's total compensation ($USD227.76K) is about average for companies of similar size in the Australian market ($USD294.75K).
Compensation vs Earnings: Peter's compensation has increased whilst the company is unprofitable.
|Chief Financial Officer||0.083yr||no data||no data|
|Chief Scientific Officer||no data||no data||no data|
|Head of Marketing||2yrs||no data||no data|
|Chief Medical Officer||no data||no data||no data|
|Head of Regulatory Affairs||1.08yrs||no data||no data|
|Executive Officer||0.083yr||no data||no data|
|Company Secretary||2.08yrs||no data||no data|
Experienced Management: FRE's management team is considered experienced (2 years average tenure).
|Non-Executive Director||2.17yrs||AU$30.00k||0.35% |
|Non-Executive Director||0.58yr||AU$30.00k||no data|
Experienced Board: FRE's board of directors are considered experienced (6.5 years average tenure).